4.4K(top 0.1%)
papers
176.0K(top 0.1%)
citations
190(top 0.1%)
h-index
321(top 0.1%)
g-index
5.2K
all documents
207.5K
doc citations
8.4K
citing journals

Top Articles

#TitleJournalYearCitations
1First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerNew England Journal of Medicine20142,886
2Genome-wide association study identifies novel breast cancer susceptibility lociNature20072,179
3Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersJAMA - Journal of the American Medical Association20172,039
4Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology20091,792
5Comprehensive genomic profiles of small cell lung cancerNature20151,744
6Crizotinib in ROS1-Rearranged Non–Small-Cell Lung CancerNew England Journal of Medicine20141,710
7Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialLancet, The20041,576
8Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNature Reviews Drug Discovery20141,312
9Whole–genome characterization of chemoresistant ovarian cancerNature20151,263
10Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyLancet, The20201,237
11Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerNature Genetics20121,216
12PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell CarcinomaNew England Journal of Medicine20181,072
13Translational biology of osteosarcomaNature Reviews Cancer20141,000
14Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryAnnals of Oncology2019925
15Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast CancerNew England Journal of Medicine2020877
16[ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 studyLancet Oncology, The2018872
17Cervical cancer: A global health crisisCancer2017858
185th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)Annals of Oncology2020854
19Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsOncotarget2016842
20A comparison of background correction methods for two-colour microarraysBioinformatics2007833
21Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports projectBlood2009832
22Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung CancerScience Translational Medicine2010763
23Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04Journal of Clinical Oncology2012759
24Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic GradeJournal of Clinical Oncology2007722
25Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaNew England Journal of Medicine2018722
26Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Journal of Clinical Oncology2010698
27Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialJournal of Clinical Oncology2010685
28Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysisEuropean Urology2020658
29Lymphangiogenesis and lymphatic vessel remodelling in cancerNature Reviews Cancer2014650
30Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovaryJournal of Pathology2010635
31[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trialLancet, The2021629
32Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T CellsClinical Cancer Research2013612
33Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsAdvances in Anatomic Pathology2017576
34Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain MetastasesJournal of Clinical Oncology2015563
35Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma ClassificationJournal of Thoracic Oncology2011556
36Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02Journal of Clinical Oncology2006533
37Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guidelinePractical Radiation Oncology2012525
38Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaLeukemia2010522
39The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevantCancer Treatment Reviews2015501
40Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further ResearchAdvances in Anatomic Pathology2017501
41Radiotherapy toxicityNature Reviews Disease Primers2019497
42A Microenvironment-Induced Myeloproliferative Syndrome Caused by Retinoic Acid Receptor γ DeficiencyCell2007496
43Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriersJournal of Medical Genetics2015488
44Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial InfarctionsJournal of Clinical Oncology2007478
45Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast CancerNew England Journal of Medicine2018475
46Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeEuropean Journal of Cancer2017465
47Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialLancet, The2017461
48Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant TherapyJournal of Clinical Oncology2020459
49Consensus guidelines for the use and interpretation of angiogenesis assaysAngiogenesis2018457
50Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic BRAF-Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF InhibitorJournal of Clinical Oncology2013449